105 related articles for article (PubMed ID: 2777057)
1. Ca2+-antagonistic properties of phospholipase A2 inhibitors, mepacrine and chloroquine.
Filippov A; Skatova G; Porotikov V; Kobrinsky E; Saxon M
Gen Physiol Biophys; 1989 Apr; 8(2):113-8. PubMed ID: 2777057
[TBL] [Abstract][Full Text] [Related]
2. The effects of non-steroidal inhibitors of phospholipase A2 on leukotriene and histamine release from human and guinea-pig lung.
Kench JG; Seale JP; Temple DM; Tennant C
Prostaglandins; 1985 Aug; 30(2):199-208. PubMed ID: 2413502
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lipid peroxidation in muscle homogenates by phospholipase A2 inhibitors.
Jackson MJ; Jones DA; Harris EJ
Biosci Rep; 1984 Jul; 4(7):581-7. PubMed ID: 6478056
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of polymorphonuclear leucocyte phospholipase A2 activity by chloroquine and mepacrine.
Authi KS; Traynor JR
J Pharm Pharmacol; 1982 Nov; 34(11):736-8. PubMed ID: 6129307
[No Abstract] [Full Text] [Related]
5. Effects of antimalarial drugs on phospholipase A and lysophospholipase activities in plasma membrane, mitochondrial, microsomal and cytosolic subcellular fractions of rat liver.
Löffler BM; Bohn E; Hesse B; Kunze H
Biochim Biophys Acta; 1985 Jul; 835(3):448-55. PubMed ID: 4016141
[TBL] [Abstract][Full Text] [Related]
6. Suppression by phospholipase A2 inhibitors of secretion of catecholamines from isolated adrenal medullary cells by suppression of cellular calcium uptake.
Wada A; Sakurai S; Kobayashi H; Yanagihara N; Izumi F
Biochem Pharmacol; 1983 Apr; 32(7):1175-8. PubMed ID: 6847709
[TBL] [Abstract][Full Text] [Related]
7. The possible role of phospholipase A2 in cardiac membrane destabilization under calcium overload conditions.
Saxon ME; Filippov AK; Porotikov UI
Basic Res Cardiol; 1984; 79(6):668-78. PubMed ID: 6532436
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
Vallee E; Gougat J; Navarro J; Delahayes JF
J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 inhibitors. Differential inhibition of fatty acid acylation into kidney lipids by mepacrine and p-bromophenacyl bromide.
Erman A; Azuri R; Raz A
Biochem Pharmacol; 1983 Jul; 32(13):2083-7. PubMed ID: 6870935
[TBL] [Abstract][Full Text] [Related]
10. Effects of phospholipase A2 inhibitors on ruthenium red-induced Ca2+ release from mitochondria.
Broekemeier KM; Schmid PC; Schmid HH; Pfeiffer DR
J Biol Chem; 1985 Jan; 260(1):105-13. PubMed ID: 2578123
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells.
Frye RA; Holz RW
Mol Pharmacol; 1983 May; 23(3):547-50. PubMed ID: 6865904
[TBL] [Abstract][Full Text] [Related]
12. Biphasic modulation of platelet phospholipase A2 activity and platelet aggregation by mepacrine (quinacrine).
Chan AC; Pritchard ET; Gerrard JM; Man RY; Choy PC
Biochim Biophys Acta; 1982 Oct; 713(1):170-2. PubMed ID: 7138896
[TBL] [Abstract][Full Text] [Related]
13. [Development of a method for the study of drugs which inhibit phospholipase A2].
Alcaraz MJ
Arch Farmacol Toxicol; 1985 Aug; 11(2):73-8. PubMed ID: 3002289
[No Abstract] [Full Text] [Related]
14. Dantrolene and mepacrine antagonize the hemolysis of human red blood cells by halothane and bee venom phospholipase A2.
Fletcher JE; Kistler P; Rosenberg H; Michaux K
Toxicol Appl Pharmacol; 1987 Sep; 90(3):410-9. PubMed ID: 3660410
[TBL] [Abstract][Full Text] [Related]
15. Mepacrine protects the isolated rat heart during hypoxia and reoxygenation--but not by inhibition of phospholipase A2.
Bugge E; Gamst TM; Hegstad AC; Andreasen T; Ytrehus K
Basic Res Cardiol; 1997 Feb; 92(1):17-24. PubMed ID: 9062648
[TBL] [Abstract][Full Text] [Related]
16. Role of phospholipases in myocardial ischemia: effect of cardioprotective agents on the phospholipases A of heart cytosol and sarcoplasmic reticulum in vitro.
Hostetler KY; Jellison EJ
Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):77-82. PubMed ID: 2779545
[TBL] [Abstract][Full Text] [Related]
17. The role of phospholipase A2 in calcium-induced damage in cardiac and skeletal muscle.
Duncan CJ
Cell Tissue Res; 1988 Aug; 253(2):457-62. PubMed ID: 3136926
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of phospholipase A2 block the stimulation of protein synthesis by insulin in L6 myoblasts.
Southorn BG; Palmer RM
Biochem J; 1990 Sep; 270(3):737-9. PubMed ID: 2241906
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of suppression of cardiac L-type Ca(2+) currents by the phospholipase A(2) inhibitor mepacrine.
Xiao YF; Zeind AJ; Kaushik V; Perreault-Micale CL; Morgan JP
Eur J Pharmacol; 2000 Jul; 399(2-3):107-16. PubMed ID: 10884509
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone directly inhibits snake venom phospholipase A.
Kato N; Halprin KM; Matsuo S; Taylor JR
Biochem Biophys Res Commun; 1985 Jul; 130(2):761-7. PubMed ID: 4026856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
